Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03261544 · ClinicalTrials.gov registry record
Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
A clinical trial of Sarcoma and Bone Metastases, sponsored by Duke University.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT03261544 is a study of Sarcoma and Bone Metastases that is actively recruiting participants, run by Duke University. The registered enrollment target is 50 participants, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03261544, a study of Sarcoma and Bone Metastases, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the functional outcomes in patients undergoing proximal femur resection and reconstruction with an endoprosthesis, based on the abductor muscle repair technique. The investigators hypothesize that those patients who receive reattachment of the abductors directly into the prosthesis will have better functional outcomes overall. Furthermore, the investigators plan to develop a simple, cost effective, and reproducible method to assess abductor function at clinical post-operative visits through plain radiographs.
Conditions Studied
Interventions
- PROCEDURE Proximal Femur Replacement
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-11-10 |
| Est. Completion | 2028-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03261544
The ClinicalTrials.gov registry entry for NCT03261544 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (95% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Sarcoma appearing as the primary indexed condition, and to 1 intervention - of which Proximal Femur Replacement is the first listed.
NCT03261544 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03261544 about?
NCT03261544 is a clinical study titled "Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?". The purpose of this study is to assess the functional outcomes in patients undergoing proximal femur resection and reconstruction with an endoprosthesis, based on the abductor muscle repair technique. The investigators hypothesize that those patients who receive reattachment of the abductors directl...
What is the current status of trial NCT03261544?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2017-11-10. Estimated completion is 2028-11.
What conditions does trial NCT03261544 study?
This clinical trial studies the following conditions: Sarcoma, Bone Metastases, Proximal Femur Replacement.
What interventions are being tested in trial NCT03261544?
The interventions under investigation include: Proximal Femur Replacement (PROCEDURE).
Who is sponsoring clinical trial NCT03261544?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03261544 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients
RECRUITING
-
Palbociclib and Pembrolizumab in Sarcoma
RECRUITING · Phase 1
-
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
RECRUITING · Phase 1
-
Enhanced Recovery After Surgery in Extremity Sarcoma
RECRUITING · NA
-
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.